Join the Oncology Voice Network. Join for Free
Objection Handling for Field Medical Professionals
MSL objection handling 5 e's framework medical science liaisons pre-call planning negotiation tactics

Objection Handling for Field Medical Professionals


Share This Article


Summary

In this episode, Linda Traylor joins Tom Caravela to delve into the art of objection handling for MSLs. They explore the nuances between MSLs and sales teams, introducing a structured approach known as the 5 e's framework. Emphasizing the significance of pre-call planning, the discussion highlights common pitfalls and strategies to prepare for frequent objections. The conversation underscores the value of team practice and the influence of MSL opinions, while stressing mentorship and collaboration. The episode wraps up with a teaser for an upcoming book review on negotiation tactics, inviting listeners to engage and apply these insights.

My guest today is Linda Traylor, Sr Principal Medical Affairs at IQVIA and we discuss objection handling for MSLs and field medical professionals.

Linda shares…

👉 How objection handling for MSLs is different than objection handling for sales reps
👉 The framework MSLs should use for objection handling
👉 What mistakes MSLs make in handling objections
👉 If MSLs should address and handle every objection
👉 The importance of preparation and pre-call planning
👉 Typical examples of objections from KOLs

Click for Source
MSL objection handling, 5 e's framework, medical science liaisons, pre-call planning, negotiation tactics

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Article
Expert perspectives live from ASCO® 2025
Partner Avatar iNIZIO

Expert perspectives live from ASCO® 2025

Explore OVN